$BHARATRAS good result is expected

harat Rasayan is a specialty agrochemical company (technical-grade pesticides). Q3 FY26 revenue Rs 287 Cr, up 9.2% YoY, with net profit Rs 40 Cr (up 44% QoQ vs Q2's Rs 28 Cr). EBITDA margin improved to 17.25% in Q3 vs 15% in Q2, signalling margin recovery trend. 9M FY26 revenue Rs 934 Cr and profit Rs 104 Cr, showing overall improvement. Key driver: global agrochemical de-stocking cycle (2023-25) now ending with restocking beginning. Peers: PI Industries reported strong Q4 with export growth; Dhanuka Agritech reported better margins; Rallis India showed recovery; Bayer CropScience (parent: Bayer AG) improved Q1 2026 globally. India rabi crop season (Jan-Mar) is key demand period for Bharat Rasayan. Board meeting May 26, 2026 to approve FY26 audited results. Promoter confidence visible (stable holding). With 9M FY26 PAT at Rs 104 Cr, Q4 required only Rs 40-50 Cr to hit FY26 targets. Margins improving YoY and industry cycle turning. Expect Q4 FY26 revenue Rs 300-320 Cr, PAT Rs 40-50 Cr, EBITDA margin 16-18%.